This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive  Media Kit

Home   About   Scholarships   Meetings   Publications   Resources   Jan. 15, 2013


Pap test could help find cancers of uterus, ovaries
The New York Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Pap test, which has prevented countless deaths from cervical cancer, may eventually help to detect cancers of the uterus and ovaries as well, a new study suggests. For the first time, researchers have found genetic material from uterine or ovarian cancers in Pap smears, meaning that it may become possible to detect three diseases with just one routine test. More

We've got you covered
Dealing with infectious samples is risky enough.
Why increase your risk by overlooking transport regulations?

Saf-T-Pak provides the solutions required for 49 CFR compliance:

Make a difference with ASCLS, CLMA, ASCP, AGT and AMT!
ASCLS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
ASCLS is proud to work with CLMA, ASCP, AMT and now AGT on the 2013 Legislative Symposium. Joining an ASCLS tradition since 1989, CLMA, ASCP, AMT and AGT members will meet with their representatives and senators on Capitol Hill as a unified front on behalf of our profession. We need you!! Click HERE for a registration form. More

CDC: Flu reaches epidemic level in US
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Influenza has officially reached epidemic proportions in the United States, with 7.3 percent of recent deaths caused by pneumonia and the flu, the U.S. Centers for Disease Control and Prevention said. That is just above the epidemic threshold of 7.2 percent. Nine of the 10 U.S. regions had "elevated" flu activity, confirming that seasonal flu has spread across the country and reached high levels several weeks before the usual time of late January or February. More

Bioengineer developing needle-free 'nanopatch' vaccines
Reuters via Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A fingertip-sized "nanopatch" covered in thousands of vaccine-coated microscopic spikes may someday transform delivery of life-saving vaccines against potentially fatal diseases. Mark Kendall, a biomedical engineer with a fascination for problem solving, has developed the device. After 160 years of using needles and syringes for immunization, he says, at-risk people — especially those in poorer, tropical, remote countries — need something simpler, more stable and easier to use. More

New solutions for unstructured data may help with clinical laboratory, anatomic pathology data
Dark Daily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Unstructured medical laboratory data is widely recognized to be one significant hurdle on the path toward the universal electronic health records. This is particularly true for anatomic pathology reports. Despite advances in synoptic reporting, to date, few pathology groups and clinical laboratories have developed ways to resolve this problem. More

CellaVision Automates and Standardizes the Manual Differential

CellaVision introduces CellAtlas®, the perfect way to learn the basics of hematology cell morphology. This App for the Apple iPhone and iPod Touch compliments our digital cell morphology portfolio, and is an educational tool to assist in the recognition and classification of blood cells, by utilizing mini-lectures and cell quizzes. More
Triturus - True Open Flexibility
As a leader in fully automated immunoassay testing systems, Grifols USA Diagnostic Division’s premier product, the TRITURUS® ELISA System is an open, fully automated, multi-test and multi-batch immunoassay system. Grifols USA is a major distributor of quality IVD ELISA tests for Infectious Disease, Autoimmune Diseases and many other disease states. Grifols’ Diagnostic products take the complexity out of clinical diagnostic testing.

Trust in Cleveland Clinic Laboratories
Cleveland Clinic Laboratories is a full-service, national reference lab dedicated to providing world class care. We have a dedicated staff of more than 1,300 employees, including board-certified subspecialty pathologists, PhDs, technologists, technicians, and support personnel. Cleveland Clinic Laboratories is proud to serve hospitals, outpatient facilities and physician offices worldwide. For more information, please visit

Removing the stigma of HIV testing
The Washington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
At the Infectious Disease Center of Excellence, housed in United Health Center in Washington, D.C., Lisa Fitzpatrick and her team provide more than just testing; they are leading a campaign to remove the stigma associated with HIV testing and being HIV-positive. More

C difficile: Synthetic stool substitute clears infection
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A synthetic stool substitute successfully ended bouts of recurrent antibiotic-resistant Clostridium difficile in a proof-of-principle study published in the inaugural issue of Microbiome. The study, which involved just two patients, suggests the promise of an off-the-shelf alternative to the transplantation of donor stool to control antibiotic-resistant intestinal bacteria. More

Study compares 3 treatment approaches in membranous nephropathy
The Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The results of a pioneering U.K.-wide clinical trial that compared treatments for patients with a common type of kidney disease has found one to be significantly more effective. The Medical Research Council-funded study, led by researchers from the University of Bristol's Academic Renal Unit based in Southmead Hospital, compared three treatment approaches in a type of kidney disorder known as "membranous nephropathy." More

Researchers study the foot soldiers of the immune system
Infection Control Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers at McGill University and the Research Center for Molecular Medicine of the Austrian Academy of Sciences have discovered the molecular blueprint behind the IFIT protein. This key protein enables the human immune system to detect viruses and prevent infection by acting as foot soldiers guarding the body against infection. More

POWERVAR - Reliable Power Since 1986
POWERVAR offers an in-depth product portfolio of real solutions and real protection for the technology your business relies on to keep your operation running smoothly. MORE
Advertise here!

To find out how to feature your company in the ASCLS eNewsletter and other advertising opportunities, Contact James DeBois at 469-420-2618.

New compound overcomes drug-resistant Staph infection in mice
University of Illinois at Urbana-Champaign via Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers have discovered a new compound that restores the health of mice infected with methicillin-resistant Staphylococcus aureus, an otherwise dangerous bacterial infection. The new compound targets an enzyme not found in human cells but which is essential to bacterial survival. More

Technique lets researchers watch cell life in real time
EPFL via Laboratory Equipment    Share    Share on FacebookTwitterShare on LinkedinE-mail article
VideoBriefAn EPFL team has developed a technique for spying on the inner lives of cells. For the first time, scientists have used a near-infrared, light-sensitive biocompatible molecule to mark and observe the activity of proteins inside living cells. More

DNA pioneer James Watson takes aim at 'cancer establishment'
Reuters via Fox News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A day after an exhaustive national report on cancer found the United States is making only slow progress against the disease, one of the country's most iconic — and iconoclastic — scientists weighed in on "the war against cancer." And he does not like what he sees. James Watson, co-discoverer of the double helix structure of DNA, lit into targets large and small. More

New study identifies significance of co-infection in disease control
Cardiff University via Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Becoming infected with one parasite could change your chances of becoming infected with another, according to new research from Cardiff University. The new study analyzes data from school-aged children in Tanzania infected with the most common forms of worms. More

ASCLS eNewsBytes

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Bob Kowalski, Content Editor, 469.420.2650   
Contribute news

This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Join ASCLS and we will subscribe you -- it's free!

Recent issues

Jan. 8, 2013
Jan. 2, 2013
Dec. 31, 2012
Dec. 24, 2012

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063